Back
Day Range
$17.08
$27.30
52-Week Range
$17.08
$27.30
Volume
143
50D / 200D Avg
$27.30
/
$23.07
Prev Close
$27.30
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.5 | 10.5 |
| P/B | 11.1 | 1.2 |
| ROE % | 91.2 | 12.3 |
| Net Margin % | 7.5 | 5.3 |
| Rev Growth 5Y % | 4.6 | 5.5 |
| D/E | 1.9 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$3.10
$2.94 – $3.23
|
8.2 B | 1 |
| FY2027 |
$2.86
$2.72 – $2.98
|
7.8 B | 1 |
| FY2026 |
$2.63
$2.50 – $2.74
|
7.4 B | 1 |
Key Takeaways
Revenue grew 4.61% annually over 5 years — modest growth
Earnings grew 23.16% over the past year
ROE of 91.18% indicates high profitability
Generating 819.21M in free cash flow
P/E of 12.51 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.68%
Growth
Revenue Growth (5Y)
4.61%
Revenue (1Y)10.29%
Earnings (1Y)23.16%
FCF Growth (3Y)-5.82%
Quality
Return on Equity
91.18%
ROIC34.09%
Net Margin7.46%
Op. Margin11.06%
Safety
Debt / Equity
1.90
Current Ratio0.52
Interest Coverage12.56
Valuation
P/E Ratio
12.51
P/B Ratio11.13
EV/EBITDA9.87
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.29% | Revenue Growth (3Y) | -1.32% |
| Earnings Growth (1Y) | 23.16% | Earnings Growth (3Y) | -11.92% |
| Revenue Growth (5Y) | 4.61% | Earnings Growth (5Y) | -2.64% |
| Profitability | |||
| Revenue (TTM) | 6.87B | Net Income (TTM) | 511.89M |
| ROE | 91.18% | ROA | 14.07% |
| Gross Margin | 30.35% | Operating Margin | 11.06% |
| Net Margin | 7.46% | Free Cash Flow (TTM) | 819.21M |
| ROIC | 34.09% | FCF Growth (3Y) | -5.82% |
| Safety | |||
| Debt / Equity | 1.90 | Current Ratio | 0.52 |
| Interest Coverage | 12.56 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 12.51 | P/B Ratio | 11.13 |
| P/S Ratio | 0.93 | PEG Ratio | 2.14 |
| EV/EBITDA | 9.87 | Dividend Yield | 0.02% |
| Market Cap | 6.40B | Enterprise Value | 7.49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.87B | 6.22B | 7.05B | 6.66B | 5.73B |
| Net Income | 511.89M | 415.62M | 659.87M | 620.33M | 569.81M |
| EPS (Diluted) | 2.19 | 1.77 | 2.81 | 2.65 | 2.43 |
| Gross Profit | 2.08B | 1.88B | 2.23B | 2.06B | 1.96B |
| Operating Income | 759.10M | 609.00M | 939.34M | 902.93M | 786.11M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.64B | 3.65B | 3.57B | 3.55B | 2.98B |
| Total Liabilities | 3.06B | 3.10B | 2.89B | 2.93B | 2.40B |
| Shareholders' Equity | 575.30M | 547.55M | 674.90M | 626.32M | 582.70M |
| Total Debt | 1.09B | 1.31B | 923.16M | 934.42M | 514.01M |
| Cash & Equivalents | 6.11M | 11.24M | 11.04M | 8.17M | 6.90M |
| Current Assets | 1.42B | 1.32B | 1.31B | 1.60B | 1.14B |
| Current Liabilities | 2.72B | 2.42B | 2.14B | 2.26B | 1.93B |
Strategy Scores
This stock passed the criteria for 0 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026